-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, Combination therapy, AML, Adult, Clinical Practice (Health Services and Quality), Drug development, Epidemiology, Elderly, Genomics, Clinical Research, Health outcomes research, Health disparities research, Pediatric, Supportive Care, Diseases, Therapy sequence, Treatment Considerations, Real-world evidence, Clinical procedures, Adverse Events, Registries, Young adult , Biological Processes, Myeloid Malignancies, Survivorship, Technology and Procedures, Molecular biology, Study Population, Human, Measurable Residual Disease , Machine learning, Molecular testing, Pathology
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Christina Darwish, MD1, Grace Van Hyfte, MSc1*, Hannah Levavi, MD2, Jonathan Feld, MD1 and Douglas Tremblay, MD1

1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Brooklyn, NY

Manar S Alfaham1,2*, Syed Osman Ahmed3*, Nogayhan Seymen2*, Mohamed Abouelhoda1*, Najlaa Filimban1*, Ahmed Alotaibi4*, Midrar Alhossiny1*, Brian Meyer1*, Abdullah Alsuwaidan1*, Hazza A. Alzahrani3*, Mahmoud Aljurf5*, Walid Rasheed5, Marwan Shaheen3*, Fahad Almohareb3, Naeem A. Chaudhri3, Fahad Alsharif3*, Amal Hejab, MD6*, Ahmed Alnughmush3, Balqees Alzayed7*, Nasir Bakshi8*, Deniz Ece Kaya2*, Mehrdad Ovesisi2*, Dorota Monies1*, Warisha Mumtaz2*, Haitham A. Khogeer8*, Riad Youniss7*, Mohammad M Karimi2* and Ghulam J Mufti2*

1Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2Comprehensive Cancer Centre, King's College London, London, United Kingdom
3Dept of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
4King Faisal Specialist Hospital and Research, Cancer Center of Excellence, Riyadh, Saudi Arabia
5Department of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
6Dept of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Shelby Township, MI
7Oncology Research Unit, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
8Dept of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Anushareddy Muddasani, MBBS1*, Rachel Hendrix, PharmD2*, Milan Bimali, PhD2* and Asis Shrestha, MD2*

1University of Arkansas for Medical Sciences, Alexander, AR
2University of Arkansas for Medical Sciences, Little Rock, AR

Michele S. Redell, MD1, Robert Gerbing, MS2*, Todd A. Alonzo, PhD3*, Jim Wang, MS4*, Maureen O'Brien, MD5*, Sarah K Tasian, MD6, Matthew A. Kutny, MD7 and Todd M Cooper, DO8

1Texas Children's Cancer Center/Baylor College of Medicine, Houston, TX
2Children's Oncology Group, Arcadia, CA
3Univ. of Southern California Keck School of Med., Monrovia, CA
4Children's Oncology Group, Monrovia, CA
5Children's Hospital Colorado, Aurora, CO
6Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
7University of Alabama Birmingham, Birmingham, AL
8Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Childrens Hospital, Seattle, WA

Nilesh Kapoor, MD1*, Ang Gao, MS2*, Ruth Ikpefan, MD3*, Chul Ahn, PhD2*, Julia Anderson, BS3*, F Neslihan Kalkan, MD3*, Weina Chen, MD, PhD4*, Sharon Germans, MD4*, Alejandro Marinos Velarde, MD3*, Vivian Irrizary Gatell, MD3*, Julio Alvarenga Thiebaud, MD5, Clayton Jackson, MD5*, Olga K. Weinberg, MD4*, Miguel Cantu, MD4*, Robert H. Collins, MD5, Stephen Chung, MD6 and Yazan F Madanat, MD5

1Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
2Peter O’Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX
3Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX
4Department of Pathology, UT Southwestern Medical Center, Dallas, TX
5Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
6Division of Hematology/Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX

Zongru Li, MD1*, Lu Yu2*, Lijuan Hu3*, Ting Zhao4*, Wenbing Duan5*, Jing Wang6*, Jinsong Jia7*, Qiang Fu8*, Ya-Zhen Qin, MD1*, Hao Jiang1*, Xiaohui Zhang, MD9, Feifei Tang10*, Yuqian Sun11*, XiaoDong Mo, MD12*, Lanping Xu13*, Yu Wang14*, Xiaojun Huang12 and Qian Jiang, MD15

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
3National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
4Peking University People’s Hospital, Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease, China, Beijing, China
5Department of Hematology, Peking University People's Hospital, Beijing, China
6Peking University People’s Hospital,Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
7Peking University People’s Hospital, Beijing, China
8Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease,Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
9Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
10Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, AL, China
11National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
12Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
13Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China
14Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China
15National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, Beijing, China

Sawyer Bawek, DO1, Steven Green, MD2*, Elizabeth A. Griffiths, MD2, James E Thompson, MD2, Pamela J. Sung, MD, PhD2, Amanda C. Przespolewski, DO2,3 and Eunice S. Wang, MD2

1University at Buffalo, Buffalo, NY
2Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Bristol-Myers Squibb, Buffalo

Shreyas Khanna1,2*, Harini Haran, MBBS, FRACP, FRCPA3*, Thomas Wiseman1,2*, Kevin Hung, MBBS, FRACP, FRCPA1, Aidan Sapio, BPharm(Hns)1*, Philip Selby, BPharm1,4*, Michaela Spooner, BSc(LabMed)1*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA1,2,5, Daniel Thomas, MD, PhD1,5,6, Chung How Kok, BSc, PhD4,7*, Andrew H Wei, MBBS, PhD, FRACP, FRCPA8,9,10, Chong Chyn Chua, MBBS, FRACP, FRCPA3,9,11 and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA1,2,4,5

1Royal Adelaide Hospital, Adelaide, SA, Australia
2University of Adelaide, Adelaide, SA, Australia
3Monash Hospital and Monash University, Rosanna, VIC, Australia
4University of South Australia, Adelaide, SA, Australia
5South Australian Health and Medical Research Institute, Adelaide, SA, Australia
6University of Adelaide, Stanford, CA
7SA Pathology, Adelaide, SA, Australia
8Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
9The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
10The University of Melbourne, Melbourne, VIC, Australia
11Northern Hospital, Epping, VIC, Australia

Pierantonio Russo, MD1,2*, Ramaa Nathan3*, Daniel Pfeffer3* and Alex Moore3*

1Corporate Medical, Eversana, Kansas City, KS
2Corporate Medical, Eversana, Cherry Hill, NJ
3Data Science, Eversana, Kansas City, KS

Paola Minetto, MD1, Carola Riva2*, Enrico Carminati, PhD1*, Ylenia Azzanelli, MD3*, Francesco Puglisi4*, Clara Nurra4*, Giuseppina Fugazza5*, Antonia Cagnetta, MD6*, Michele Cea7,8*, Roberto Massimo Lemoli, MD3,9* and Fabio Guolo, MD, PhD10

1IRCCS Ospedale Policlinico San Martino, Genoa, Italy
2Clinic of Hematology, Department of Internal medicine (DiMI), University of Genoa, Genova, AL, Italy
3Clinic of Hematology, Department of Internal medicine (DiMI), University of Genoa, Genoa, Italy
4Clinic of hematology, Department of Internal medicine (DiMI), University of Genoa, Genoa, Italy
5Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
6Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
7IRCCS Ospedale Policlinico San Martino, Genova, Italy
8Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genova, Italy
9Clinica Ematologica, Dipartimento di Oncologia e Ematologia, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
10Hematology Unit, Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy

Fei Xu1*, Enbo Chen2*, Yan Li1*, Bobin Su1* and Jian Ge1*

1Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
2Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, AL, China

Brian Parkin, MD1, Caralyn Escobar, PharmD2*, Roma Patel2*, Tori Smith, APRN2*, Amy Browning, APRN2*, Philip A. Pancari, MD2*, Arlene A. Gayle, MD2 and Shahram Mori, MD, PhD2

1Translational Research Institute, AdventHealth, Orlando, FL
2AdventHealth, Orlando, FL

Andrew F. Berdel, MD1*, Julian Ronnacker, MD1*, Daniela V. Wenge, MD1,2*, Lina Kolloch, MD1*, Philipp Berning, MD1,3*, Linus Angenendt, MD1,4*, Tobias Brix5*, Annette Westermann1*, Klaus Wethmar, MD1*, Torsten Kessler, MD1*, Andrea Kerkhoff, MD6*, Rolf M. Mesters, MD1*, Christian Reicherts, MD1*, Jan-Henrik Mikesch, MD6*, Wolfgang E. Berdel, MD1, Georg Lenz6, Christoph Schliemann, MD7* and Matthias Stelljes, MD6*

1Department of Medicine A (Hematology, Hemostaseology, Oncology, Pneumology), University Hospital Muenster, Muenster, Germany
2Dana-Farber Cancer Institute, Boston, MA
3Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
4Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland
5Institute of Medical Informatics, University Hospital Muenster, Muenster, Germany
6Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
7Department of Medicine A, University Hospital Muenster, Muenster, Germany

Philip A Haddad, MD1, Sireesha Vutukuri, MD2* and Ankita Gupta, MD3*

1Feist-Weiller Cancer Center, LSUHSC-S/Overton Brooks VAMC, Shreveport, LA
2Overton Brooks VAMC, Shreveport, LA
3LSUHSC-S/Overton Brooks VAMC, Shreveport

Osama Batayneh1, Deevyashali Parekh, MD2*, Margarita Vazquez Almonte3, Cristina Hamacher, DO4*, Angela Gupta5*, Michael Sandhu, MD6, Sanjay Rao Gergal Gopalakrishna Rao, MBBS2*, Alyssa Cortese, MD7*, Danielle Passafiume5*, Carina Hernandez, MD, PhD2*, Safa Afridi, MBBS2*, Kelsey Christo5*, Josh Wallace5* and Teresa Gentile, MD, PhD7

1Department of Hematology/Oncology, SUNY Upstate University, Syracuse, RI
2Department of Internal Medicine, SUNY Upstate University, Syracuse, NY
3SUNY Upstate Medical University, Bronx, NY
4Department of Internal Medicine, Brown University/ Kent Hospital, Providence, RI
5SUNY Upstate University, Syracuse, NY
6Department of Hematology/Oncology, Montefiore Medical Center, New York City, NY
7Department of Hematology/Oncology, SUNY Upstate University, Syracuse, NY

Srinishant Rajarajan, MBBS1, Kalaivani Babu, MBBS1, Alexander Helfand, MD2*, Arya Mariam Roy, MD3, Asmi Chattaraj2, Sruthi P Ramanan, MBBS4, Nithya Ramesh, MD2, Adanma Anji Ayanambakkam Attanathi, MD5* and Amit Correa, MD6*

1Internal Medicine, Allegheny General Hospital, Pittsburgh, PA
2Allegheny General Hospital, Pittsburgh, PA
3Rosewell Park Cancer Center, Buffalo, NY
4Allegheny General hospital, Pittsburgh, PA
5Oklahoma University Health Sciences, Oklahoma City, OK
6Memorial Hermann, McGovern Medical School, Houston

Ekrem Turk, MD1, Maha Elsebaie, MD2, Vaishali Deenadayalan, MD3, Khaldun Obeidat, MD4, Ahmad Nanaa, MD5, Maryam Zia, MD6 and Noah Birch, MD, PhD7*

1John H Stroger Hospital Jr Hospital of Cook County, Chicago, IL
2Hematology and Oncology, University of Chicago, Chicago
3Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Department of Medicine, University of Wisconsin, Madison, WI
5Hematolog and Oncology, University of Illinois Chicago, Chicago
6Hematology-Oncology & Cellular Therapy (Division), SSM Health Saint Louis University Hospital, St. Louis, MO
7Division of Hematology & Oncology, University of Illinois Chicago, Chicago, IL

Naseema Gangat, MBBS1, Azeem Elbeih, MD2*, Nour Ghosoun, MD2*, Kristen B. McCullough, PharmD3, Isla Johnson, MD4, Maymona Abdelmagid, MD5*, Aref Al-Kali, MD6, Hassan B Alkhateeb, MD1*, Kebede Begna, MD5, Michelle A Elliott, MD2, Abhishek A. Mangaonkar, MBBS2, Aasiya Matin, MD7, Antoine N. Saliba, MD1, Mehrdad Hefazi, MD1, Mark R. Litzow, MD1, William J. Hogan, MD1, Mithun V Shah, M.D., Ph.D.1, Mrinal M. Patnaik, MD, MBBS2, Animesh D. Pardanani, MBBS, PhD5, Talha Badar, MD8, Hemant S. Murthy, MD9, James M. Foran, MD10, Jeanne Palmer, MD11, Lisa Sproat, MD12, Nandita Khera, MD12, Cecilia Y. Arana Yi, MD13 and Ayalew Tefferi, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic Hospital-Rochester, Rochester, MN
4Mayo School of Graduate Medical Education,, Rochester, MN
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
6Mayo Clinic, Rochester
7Hematology, Mayo Clinic, Rochester, MN
8Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
9Mayo Clinic, Jacksonville, FL
10Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
11Mayo Clinic - Arizona, Scottsdale, AZ
12Mayo Clinic, Phoenix, AZ
13Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ

Heya Batah, MD1*, Daniel P. Nurse, DO2, Jessica El-Asmar, MD, MPH3, Ameed Bawwab, MD1*, Yomna Abu-Farsakh, MD4*, Moath Albliwi, MD1*, John Hanna, MD1, Asad Rauf1*, Hasan Abuamsha1*, Emily C. Zabor, DrPH5*, Yohanna B. Bedelu5*, Mark Jinan Chen, PhD6*, Joy Nakitandwe, PhD6*, Akriti G. Jain, MD3, John C. Molina, MD, MEd3, Sophia Balderman, MD3*, Abhay Singh, MD, MPH3, Aaron T. Gerds, MD, MS3, Sudipto Mukherjee, MD, PhD, MPH3, Anjali S. Advani, MD3, Hetty E. Carraway, MD, MBA3 and Moaath K. Mustafa Ali, MD, MPH3

1Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
2Department of Internal Medicine, Cleveland Clinic, University Heights, OH
3Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, North Canton, OH
5Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
6Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH

Ameed Bawwab, MD1*, Daniel P. Nurse, DO2*, Jessica El-Asmar, MD, MPH3, Yomna Abu-Farsakh, MD4*, Moath Albliwi, MD2*, John Hanna, MD2, Asad Rauf2*, Heya Batah, MD2*, Hasan Abuamsha2*, Emily C. Zabor, DrPH5*, Yohana B. Bedelu5*, Mark Jinan Chen, PhD6*, Joy Nakitandwe, PhD6*, Akriti G. Jain, MD3, John C. Molina, MD, MEd3, Sophia Balderman, MD3*, Abhay Singh, MD, MPH3, Aaron T. Gerds, MD, MS3, Sudipto Mukherjee, MD, PhD, MPH3, Anjali S. Advani, MD3, Hetty E. Carraway, MD, MBA3 and Moaath K. Mustafa Ali, MD, MPH3

1Department of Internal Medicine, Cleveland Clinic, Akron, OH
2Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
3Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, North Canton, OH
5Department of Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
6Department of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, OH

Changqing Jiao*, Jianling Cui*, Junjie Zhou* and Jian Ge*

Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China

Jayastu Senapati, MD, DM, MBBS1, Hagop M. Kantarjian, MD1, Guillermo Garcia-Manero, MD1, Nicholas J. Short, MD1, Fadi G. Haddad, MD1, Naval Daver, MD2, Courtney D. DiNardo, MD, MSc3, Gautam Borthakur, MD4, Joseph E. Jabbour5*, Naveen Pemmaraju, MD6, Amin M. Alousi, MD5*, Elizabeth J. Shpall, MD5, Alexandre Bazinet, MD1*, Kelly S. Chien, MD7, Danielle Hammond, MD1, Sherry Pierce, BSN, BA1*, Farhad Ravandi, MBBS8 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
7Department of Leukemia, MD Anderson, Houston, TX
8Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Giovangiacinto Paterno1*, Flavia Mallegni2*, Elisa Buzzatti2*, Maria Irno Consalvo3*, Elisa Meddi2*, Federico Moretti2*, Lucrezia De Marchi2*, Kristian Taka2*, Camilla Page2*, Massimiliano Marinoni2, Luca Maurillo, MD1*, Carmelo Gurnari, MD, PhD2, Raffaele Palmieri2*, Francesco Buccisano, MD2, Adriano Venditti2 and Maria Ilaria Del Principe2*

1Hematology, Fondazione Poliniclinico Tor Vergata, Rome, Italy
2Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
3Advanced Oncohematological Diagnostics, Fondazione Policlinico Tor Vergata, Roma, Italy

Cameron J. Hunter1, Jan Philipp Bewersdorf, MD1, Lourdes Mendez, MD1*, Nikolai A. Podoltsev, MD, PhD2, Amer M. Zeidan, MBBS, MHS1, William Eighmy, PharmD3*, Heidi Roeder, PharmD3*, Maricar Malinis, MD4* and Rory M. Shallis, MD5

1Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, New Haven, CT
2Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Department of Pharmacy, Section of Oncology, Yale New Haven Health, New Haven, CT
4Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT
5Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT

Asmita Shukla, MD1, Dakshin Padmanabhan, MBBS2, Paul Kim, BA3*, Jeff Aguilar, MD, MBA3*, Sushmitha Nanja Reddy, MD, MBBS4, Vikram Dhillon, DO, MBA5*, David Carr, MD6*, Jay Yang, MD6, Julie Boerner6* and Suresh Kumar Balasubramanian, MD7,8

1Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI
2Internal Medicine, Trinity Health Oakland Hospital, Rochester Hills, MI
3Karmanos Cancer Institute/Wayne State University, Detroit, MI
4Department of Oncology, Karmanos Cancer Institute/Wayne State University, Novi, MI
5Department of Hematology/Oncology, Neal Cancer Center/Houston Methodist Hospital, Detroit, MI
6Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
7Department of Oncology, Karmanos Cancer Institute/Wayne State University, Troy, MI
8Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

*signifies non-member of ASH